Bank of New York Mellon’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $424K | Buy |
375,037
+43,845
| +13% | +$49.5K | ﹤0.01% | 3583 |
|
2025
Q1 | $484K | Buy |
331,192
+423
| +0.1% | +$618 | ﹤0.01% | 3441 |
|
2024
Q4 | $705K | Buy |
330,769
+13,150
| +4% | +$28K | ﹤0.01% | 3324 |
|
2024
Q3 | $889K | Sell |
317,619
-44,745
| -12% | -$125K | ﹤0.01% | 3196 |
|
2024
Q2 | $844K | Buy |
362,364
+61,811
| +21% | +$144K | ﹤0.01% | 3286 |
|
2024
Q1 | $1.34M | Sell |
300,553
-23,428
| -7% | -$105K | ﹤0.01% | 2988 |
|
2023
Q4 | $1.04M | Buy |
323,981
+13,167
| +4% | +$42.3K | ﹤0.01% | 3163 |
|
2023
Q3 | $985K | Buy |
310,814
+1,928
| +0.6% | +$6.11K | ﹤0.01% | 3153 |
|
2023
Q2 | $1.54M | Sell |
308,886
-41,283
| -12% | -$205K | ﹤0.01% | 2972 |
|
2023
Q1 | $1.73M | Buy |
350,169
+41,747
| +14% | +$206K | ﹤0.01% | 2879 |
|
2022
Q4 | $1.94M | Buy |
308,422
+19,900
| +7% | +$125K | ﹤0.01% | 2867 |
|
2022
Q3 | $3.12M | Buy |
288,522
+40,141
| +16% | +$433K | ﹤0.01% | 2563 |
|
2022
Q2 | $2.83M | Sell |
248,381
-50,866
| -17% | -$580K | ﹤0.01% | 2639 |
|
2022
Q1 | $2.73M | Buy |
299,247
+569
| +0.2% | +$5.18K | ﹤0.01% | 2766 |
|
2021
Q4 | $4.46M | Sell |
298,678
-20,127
| -6% | -$300K | ﹤0.01% | 2523 |
|
2021
Q3 | $8.19M | Buy |
318,805
+36,468
| +13% | +$937K | ﹤0.01% | 2230 |
|
2021
Q2 | $7.36M | Buy |
282,337
+60,187
| +27% | +$1.57M | ﹤0.01% | 2290 |
|
2021
Q1 | $7.84M | Sell |
222,150
-8,016
| -3% | -$283K | ﹤0.01% | 2228 |
|
2020
Q4 | $5.81M | Buy |
230,166
+6,947
| +3% | +$175K | ﹤0.01% | 2292 |
|
2020
Q3 | $8.42M | Sell |
223,219
-5,110
| -2% | -$193K | ﹤0.01% | 1946 |
|
2020
Q2 | $9.78M | Buy |
228,329
+69,663
| +44% | +$2.98M | ﹤0.01% | 1851 |
|
2020
Q1 | $3.08M | Buy |
158,666
+2,076
| +1% | +$40.4K | ﹤0.01% | 2313 |
|
2019
Q4 | $4.07M | Buy |
156,590
+8,801
| +6% | +$229K | ﹤0.01% | 2436 |
|
2019
Q3 | $4.03M | Buy |
147,789
+13,979
| +10% | +$381K | ﹤0.01% | 2388 |
|
2019
Q2 | $3.59M | Buy |
133,810
+55,743
| +71% | +$1.5M | ﹤0.01% | 2494 |
|
2019
Q1 | $2.26M | Buy |
78,067
+43,099
| +123% | +$1.25M | ﹤0.01% | 2715 |
|
2018
Q4 | $941K | Buy |
+34,968
| New | +$941K | ﹤0.01% | 3137 |
|